Palatin prelim Q4 Vyleesi net revenue $1.7M, up 122% YoY; prescriptions +89% YoY

PALATIN TECHNOLOGIES INC

Gross product revenue $4.1M, up 20% QoQ and 78% YoY.
Net product revenue $1.7M, up 42% QoQ and 122% YoY.
Prescriptions dispensed increased 14% QoQ and 89% YoY.
New healthcare prescribers up 20% QoQ; 6 consecutive quarters of double-digit growth.
Management states net revenue per prescription continues to improve, exceeding quarterly operating expenses.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.